Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hubschwerlen

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nature|January 18, 1990
Refined crystal structure of beta-lactamase from Citrobacter freundii indicates a mechanism for beta-lactam hydrolysisC Oefner, A D'Arcy, J J Daly, et al.
Journal of Medicinal Chemistry|June 1, 2001
2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitorsC Apfel, D W Banner, D Bur, et al.
Journal of Medicinal Chemistry|July 6, 2000
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agentsC Apfel, D W Banner, D Bur, et al.
Journal of Medicinal Chemistry|October 10, 1998
Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactamsI Heinze-Krauss, P Angehrn, R L Charnas, et al.
Journal of Medicinal Chemistry|April 26, 1996
Synthesis and structure-activity relationship of (lactamylvinyl)cephalosporins exhibiting activity against staphylococci, pneumococci, and enterococciI Heinze-Krauss, P Angehrn, P Guerry, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nature|January 18, 1990
Refined crystal structure of beta-lactamase from Citrobacter freundii indicates a mechanism for beta-lactam hydrolysisC Oefner, A D'Arcy, J J Daly, et al.
Journal of Medicinal Chemistry|June 1, 2001
2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitorsC Apfel, D W Banner, D Bur, et al.
Journal of Medicinal Chemistry|July 6, 2000
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agentsC Apfel, D W Banner, D Bur, et al.
Journal of Medicinal Chemistry|October 10, 1998
Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactamsI Heinze-Krauss, P Angehrn, R L Charnas, et al.
Journal of Medicinal Chemistry|April 26, 1996
Synthesis and structure-activity relationship of (lactamylvinyl)cephalosporins exhibiting activity against staphylococci, pneumococci, and enterococciI Heinze-Krauss, P Angehrn, P Guerry, et al.
Pageof 2